It could have damaging effects in cerebral ischemia [61], [62], and inhibition of NF-κB decreases neointimal formation [63], [64], [65] and reduces infarct volume and neurological deficits after stroke [66]. This evidence concerns the gene NFKB1 and stroke disorder.